Tuesday, January 09, 2018 10:15 PM ET
Insider at Biohaven Pharmaceutical Holding (BHVN) Makes Significant Sale of Stock
One insider — Portage Biotech Inc, 10% Owner — today, sold 84,881 shares of Biohaven Pharmaceutical Holding having a market value of approximately $2,551,573, as disclosed in a form 4 document filed with the SEC. There have been 4 insiders with buy/sell transactions in the past 90 days prior to this filing. All of these trades have been sales resulting in the sale of 474,600 company shares. Adding the most recent activity to this 90-day history indicates insider trades have seen net sales of 559,481 shares and have averaged 111,896 shares per transaction over this time period.
Over the last 90 days, the number of insider buy/sell trades at Biohaven Pharmaceutical Holding is higher than its 191-company peer group average. The Biotechnology & Medical Research peer group saw 163 buy/sell trades during this period for an average of 0.9 transactions per company. However, the number of shares traded per transaction by Biohaven Pharmaceutical Holding insiders is lower than its peers. Within the peer group there were 26,485,061 shares purchased and 11,532,056 shares sold with company insiders acquiring 123,579 shares on average over this time period.
The data obtained in evaluating and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at firstname.lastname@example.org. Copyright 2018 UpTick Data Technologies. All rights reserved.